drugset / Trial / NCT00002169

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

NCT00002169

Phase 2 Completed Agouron Pharmaceuticals
Treatment

Summary

The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are already being treated for cytomegalovirus (CMV) retinitis.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nelfinavir Other / unclassified